We are live on
!
Find out more
ANI Pharmaceuticals
ANIP
ANIP
34 hedge funds and large institutions have $4.84M invested in ANI Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 34 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
741% more call options, than puts
Call options by funds: $496K | Put options by funds: $59K
Holders
34
Holders Change
+34
Holders Change %
–
% of All Funds
1.11%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
34
Increased
–
Reduced
–
Closed
–
Calls
$496K
Puts
$59K
Net Calls
+$437K
Net Calls Change
+$437K
Top Buyers
No buyers this quarter
Top Sellers
No sellers this quarter
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | +$1.18K | +168 | New |
|
|
LTFS
27
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | +$1.51K | +216 | New |
|
|
LFG
28
LifePlan Financial Group
Dayton,
Ohio
| – | +$7 | +1 | New |
|
29
Wells Fargo
San Francisco,
California
| – | +$7 | +1 | New |
|
|
SSG
30
Summit Securities Group
New York
| – | +$14 | +2 | New |
|
31
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| – | +$28 | +4 | New |
|
32
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | +$91 | +13 | New |
|
|
DADC
33
D.A. Davidson & Co
Great Falls,
Montana
| – | +$196 | +28 | New |
|
|
WA
34
WFG Advisors
Dallas,
Texas
| – | +$196 | +28 | New |
|
ANIP Hedge Fund Activity: Q2 2013 in Review
34 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in ANI Pharmaceuticals (ANIP) for Q2 2013, worth a combined $4.84M.
Buyers outnumbered sellers: 34 funds opened new ANIP positions and 0 closed out — a net gain of 34 holders — while 0 added to existing stakes and 0 trimmed.
- 34 institutional investors held ANI Pharmaceuticals (ANIP) as of Q2 2013, up from 0 in Q1 2013.
- Funds reported $4.84M of ANI Pharmaceuticals stock for Q2 2013.
- 34 funds opened new ANI Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +34 holders.
Based on aggregated 13F filings for Q2 2013.